huahaipharm(600521.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
huahaipharm
600521.SH
Zhejiang Huahai Pharmaceutical Co., Ltd. engaged in the research, development, production and sales of generic drugs, biological drugs, and APIs in multiple dosage forms in China and internationally. The company offers central neurological, cardiovascular, anti-viral, and other products, as well as APIs and intermediates. It also provides packaging components, such as polyethylene bottles and polypropylene caps for pharmaceuticals.
2.805 T
600521.SHMarket value -Rank by Market Cap -/-

Financial Score

19/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking76/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreC
    • ROE3.80%C
    • Profit Margin4.36%C
    • Gross Margin57.67%B
  • Growth ScoreD
    • Revenue YoY-9.17%D
    • Net Profit YoY-67.42%E
    • Total Assets YoY3.34%C
    • Net Assets YoY-0.49%D
  • Cash ScoreC
    • Cash Flow Margin384.17%A
    • OCF YoY-9.17%D
  • Operating ScoreC
    • Turnover0.39C
  • Debt ScoreC
    • Gearing Ratio55.64%C

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    Chinese Drugmaker Huahai Rises After Signing USD340 Million Deal With Spain’s Almirall

    Yicai·
    SH
    600521
    +1.36%
    Yicai·
    SH
    600521
    +1.36%

    The CSI Convertible Bond Index opened down 0.38%. Jiaze Convertible Bonds, Jingda Convertible Bonds, Bester Convertible Bonds, TZTEK Convertible Bonds, and HUAYA INTELLIGENCE Convertible Bonds saw the largest declines, falling 3.04%, 2.99%, 2.97%, 2.74%, and 2.69% respectively. ChangGao NEET Convertible Bonds, Shandong Head Group Convertible Bonds, TRE Convertible Bonds, JINHONG GAS Convertible Bonds, and huahaipharm Convertible Bonds led the gains, rising 30.00%, 10.00%, 3.87%, 3.83%, and 3.56% respectively

    Wallstreetcn·
    SH
    600521
    +1.36%
    SH
    688106
    +0.96%
    SH
    中证转债
    0.00%
    Wallstreetcn·
    SH
    600521
    +1.36%
    SH
    688106
    +0.96%
    SH
    中证转债
    0.00%

    National Healthcare Security Administration: Key drug "Deferasirox" for treating "thalassemia" included in medical insurance

    36Kr·
    SZ
    002038
    +0.48%
    SH
    512290
    +0.21%
    SZ
    000963
    +0.07%
    36Kr·
    SZ
    002038
    +0.48%
    SH
    512290
    +0.21%
    SZ
    000963
    +0.07%

    Huahaipharm's subsidiary, Ruixiqi's Bevacizumab Injection marketing authorization application has been accepted

    Zhitong·
    SH
    600521
    +1.36%
    Zhitong·
    SH
    600521
    +1.36%

    Huahaipharm: Carboxymethyl Sodium Injection has obtained a drug registration certificate

    Zhitong·
    SH
    600521
    +1.36%
    Zhitong·
    SH
    600521
    +1.36%
    © 2026 Longbridge｜Disclaimer